Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Novartis receives FDA approval for expanded use of Zykadia®

Saturday, May 27, 2017

Novartis today announced the US Food and Drug Administration FDA approved the expanded use of Zykadia ceritinib to include the firstline treatment of patients with metastatic nonsmall cell lung cancer NSCLC whose tumors are anaplastic lymphoma kinase ALKpositive as detected by an FDAapproved test Zy..

Kite Receives U.S. Food and Drug Administration Priority Review for Axicabtagene Ciloleucel

Saturday, May 27, 2017

Kite Pharma Inc a leading cell therapy company announced that the US Food and Drug Administration FDA has accepted for priority review the Biologics License Application BLA for axicabtagene ciloleucel The submission follows positive data demonstrated with a single infusion of axicabtagene ciloleucel..

Optum and Merck Collaborate to Advance Value-Based Contracting of Pharmaceuticals

Friday, May 26, 2017

Optum the health services business of UnitedHealth Group and Merck will collaborate to develop and simulate the performance of contractual reimbursement models in which payment for prescription drugs is aligned more closely with patient health outcomes Through a multiyear collaboration on a share..

PharmaMar and Eczacibasi Sign a Licensing Agreement for Aplidin® in Turkey

Friday, May 26, 2017

PharmaMar has announced a licensing agreement with Eczacibasi Group to commercialize the marinederived anticancer drug Aplidin plitidepsin in Turkey Under the terms of the agreement PharmaMar will receive an upfront payment as well as development milestones related to the health approval procedure o..

LSNE Contract Manufacturing Announces Manufacturing Agreement with Selecta Biosciences, Inc.

Thursday, May 25, 2017

LSNE Contract Manufacturing announced today that they have signed a manufacturing supply agreement with Selecta Biosciences Inc Selecta is a clinicalstage biopharmaceutical company focused on utilizing its Synthetic Vaccine Particle SVP platform to develop biologic therapies for rare and serious dis..

JSR Life Sciences expands production capacity at KBI Biopharma

Thursday, May 25, 2017

JSR Life Sciences JLS announced that KBI Biopharma KBI a subsidiary of JSR Corporation JSR manufacturing capacities and capabilities of their facilities in Durham North Carolina and Boulder Colorado KBI is investing around 30 million US dollars in two site expansion projects This should significant..

Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset from ImmunoGen

Wednesday, May 24, 2017

Debiopharm International SA part of Debiopharm Group a Switzerlandbased biopharmaceutical company and ImmunoGen Inc a leader in the expanding field of antibodydrug conjugates ADCs for the treatment of cancer today announced that Debiopharm has acquired ImmunoGens IMGN529DEBIO 1562 a clinicalstage an..

Palladio Biosciences Formed to Develop Transformative Medicines for Orphan Diseases of the Kidney

Wednesday, May 24, 2017

Palladio Biosciences Inc a private biopharmaceutical company founded to develop medicines that make a meaningful impact on the lives of patients with orphan diseases of the kidney announced today that it has acquired global rights to lixivaptan a selective vasopressin V2 receptor antagonist from Chi..

PCI Biotech and RXi Pharmaceuticals Extend Research Collaboration to the Field of Immuno-oncology

Tuesday, May 23, 2017

PCI Biotech a cancer focused biopharmaceutical company and RXi Pharmaceuticals NASDAQ RXII a biotechnology company focused on developing novel RNAi therapeutics for significant unmet needs today announced that they are extending their preclinical research collaboration initiated April 7 2015 This..

Miraca Life Sciences Again Expands Therapeutic Drug Monitoring with Addition of First Biosimilar Inflectra®

Tuesday, May 23, 2017

Miraca Life Sciences the largest US independent anatomic pathology laboratory has further expanded its InformTx therapeutic drug monitoring TDM capabilities with the addition of testing for Inflectra infliximabdyyb which is the first biosimilar drug in the test offering Since launching InformTx in J..

TOP